School of Medicine
Showing 231-240 of 731 Results
-
Karen G. Hirsch, MD
Professor of Neurology and Neurological Sciences (Adult Neurology)
Current Research and Scholarly InterestsDr. Karen G. Hirsch cares for critically ill patients with neurologic disorders in the intensive care unit. Dr. Hirsch's research focuses on using continuous and discrete multi-modal data to develop phenotypes and identify signatures of treatment responsiveness in patients with coma after cardiac arrest. She is the Co-PI of PRECICECAP (PRecision Care In Cardiac ArrEst - ICECAP, NINDS R01 NS119825-01). The research team works closely with collaborators in data science at Stanford and with industry partners to apply machine learning analyses to complex multi-modal ICU data. Dr. Hirsch also studies neuro-imaging in post-cardiac arrest coma and traumatic brain injury, and with colleagues in Cardiac Anesthesia and Cardiothoracic Surgery, Dr. Hirsch studies neurologic outcomes in patients on mechanical circulatory support including ECMO.
Along with colleagues in Biomedical Ethics, Dr. Hirsch studies brain death, organ donation, and neuroethics. She is the Co-PI of BCI-DEF (Brain Computer Interfaces and Disability: Developing an Inclusive Ethical Framework, NIMH 1R01MH130518-01) which is a BRAIN Initiative funded study that is qualitatively evaluating end user perspectives about the benefits, risks, and ethical challenges of Brain Computer Interfaces for patients with acute stroke or traumatic brain injury.
Dr. Hirsch is broadly interested in improving neurologic outcomes after acute severe brain injury, identifying early phenotypes to guide precision medicine in neurocritical care, and exploring ethical issues in neurocritical care and novel neurotechnology. Dr. Hirsch greatly appreciates the importance of team science and collaboration. -
Mark Hlatky, MD
Professor of Health Policy, of Medicine (Cardiovascular Medicine), Emeritus
Current Research and Scholarly InterestsMy main research work is in "outcomes research", especially examining the field of cardiovascular medicine. Particular areas of interest are the integration of economic and quality of life data into randomized clinical trials, evidence-based medicine, decision models, and cost-effectiveness analysis. I am also interested in the application of novel genetic, biomarker, and imaging tests to assess risk and guide clinical management of coronary artery disease.
-
Rachel K. Hopper, MD
Clinical Professor, Pediatrics - Cardiology
Current Research and Scholarly InterestsCurrent research interests include:
Pulmonary hypertension related to prematurity and bronchopulmonary dysplasia
Right heart failure in children with pulmonary hypertension, imaging and biomarkers
Pulmonary hypertension in children with congenital heart disease and/or left-sided heart failure
Clinical trials in children with pulmonary hypertension -
Benjamin Davies Horne
Adjunct Clinical Associate Professor, Medicine - Cardiovascular Medicine
BioDr. Benjamin Horne is an Adjunct Clinical Associate Professor who is based at the Intermountain Medical Center Heart Institute in Salt Lake City, UT, where he serves as the Director of Cardiovascular and Genetic Epidemiology. His doctoral training (PhD) in genetic epidemiology was completed at the University of Utah and he holds masters degrees in public health and in biostatistics. Dr. Horne is a fellow of the American Heart Association, a fellow of the American College of Cardiology, and a member of the American Society of Human Genetics. Dr. Horne’s research focuses on population health and precision medicine, including evaluating the genetic epidemiology of heart diseases, developing and implementing clinical decision tools for personalizing medical care, discovering the human health effects of intermittent fasting, and studying the influences of air pollution on major adverse health events.
-
Ngan F. Huang
Associate Professor of Cardiothoracic Surgery (Cardiothoracic Surgery Research) and, by courtesy, of Chemical Engineering
Current Research and Scholarly InterestsDr. Huang's laboratory aims to understand the chemical and mechanical interactions between extracellular matrix (ECM) proteins and pluripotent stem cells that regulate vascular and myogenic differentiation. The fundamental insights of cell-matrix interactions are applied towards stem cell-based therapies with respect to improving cell survival and regenerative capacity, as well as engineered vascularized tissues for therapeutic transplantation.
